[Course of prostate cancer].
From the epicritical comparison of 85 histologically ascertained carcinomas of the prostate in the 10-year interval and 105 cases in the 5-year interval in the own clinic result survival times of on an average 2.7 years or absolutely of 19.5%. References to the improvement of the prognosis in early recognition, radical operation and chemotherapeutic treatment are given.
D000230:Adenocarcinoma / Q000473:pathology; D002277:Carcinoma / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000473:pathology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy
Zum Verlauf des Prostatakarzinoms.